Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMSAM vs ENCORAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMSAM vs ENCORAFENIB: Safety Overview

Metric EMSAM ENCORAFENIB
Total FAERS Reports 113 8,554
Deaths Reported 0 1,397
Death Rate N/A 16.3%
Hospitalizations 1 2,334
Average Patient Age 55.2 yrs 64.4 yrs
% Female Patients N/A 50.9%
FDA Approval Date N/A Jun 27, 2018
Manufacturer N/A Array BioPharma Inc.
Route N/A ORAL
Marketing Status N/A Discontinued